Document Detail


ACOG Committee Opinion No. 449: Maternal phenylketonuria.
MedLine Citation:
PMID:  20134300     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Phenylketonuria (PKU) is an autosomal recessive disorder of phenylalanine (Phe) metabolism characterized by a deficiency of the hepatic enzyme, phenylalanine hydroxylase, an enzyme responsible for the conversion of phenylalanine to tyrosine, and elevated levels of Phe and Phe metabolite. All women with PKU or hyperphenylalaninemia should be strongly encouraged to receive family planning and preconception counseling. Women with PKU or hyperphenylalaninemia should begin appropriate, medically directed dietary phenylalanine restriction before conception.
Authors:
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  114     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2010-02-05     Completed Date:  2010-03-08     Revised Date:  2011-01-06    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1432-3     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Family Planning Services*
Female
Fetal Diseases / prevention & control*
Genetic Counseling*
Humans
Phenylketonuria, Maternal / diagnosis,  diet therapy*
Pregnancy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ACOG Committee Opinion No. 448: Menstrual manipulation for adolescents with disabilities.
Next Document:  ACOG Committee Opinion No. 451: Von Willebrand disease in women.